Connect with us
In 2022, the company's results stood at €15.6 million, which translates into a rise of 47.2% compared to the previous year. However, in the same period,...
Grifols has lost around 70% of its market value since the start of the pandemic. In the eyes of investors, its main burdens are debt, which...
Vitro works mainly with public health, which represents between 80% and 85% of its business, and with large private chains. The biotech company has grown to...
Peaches Biotech is specialized in the creation of medicines based on advanced therapies, especially with cytokines, stem cells, or T-lymphocytes, which will allow patients to take...
Arthex Biotech is a spin-off of the University of Valencia (UV). Established in September 2019, the company focuses on the development of a treatment for myotonic...
Ability Pharma has closed 2022 with a turnover of €2.3 million, which translates into an increase of 53% compared to the income of 2021. For its...
In 2021, the company achieved a CE marking from the European Union for the world's first exoskeleton to help pediatric patients with spinal muscular atrophy (SMA) walk. The...
Arthex Biotech is a spin-off of the University of Valencia (UV). Incorporated in September 2019, the company has its focus on the development of a treatment...
At the Madrid center, Peaches Biotech is developing a bio incubator focused on research and innovation (R&D) and aims to promote translational projects in the areas...
Biocross, founded in 2005 as a spin-off of the Spanish National Research Council (CSIC), develops in-vitro diagnostic systems with multiple applications in prevention, clinical research, early...